Effectiveness of Rituximab and Its Biosimilar in Treating Adult Steroid-Dependent Minimal Change Disease and Relapse

被引：0

作者：

Shan, Hui Yi ^{[1
]}

机构：

[1] Keck Sch Med Univ Southern Calif, Dept Med, Nephrol & Hypertens, Los Angeles, CA 90033 USA

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 11期

关键词：

frequent relapses; steroid-dependent minimal change disease; rituximab biosimilar; ruxience; rituximab; minimal change disease;

D O I：

10.7759/cureus.49200

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Minimal change disease (MCD) is an important cause of nephrotic syndrome in adults. Its course is often complicated by frequent relapses and steroid dependence. Most of the treatment experience of MCD comes from management of pediatric patients rather than adult patients. In this report, the author describes successful experience of using rituximab (RTX) and its biosimilar, RTX-pvvr (ruxience), to treat steroid -dependent MCD and relapses in adult patients. This is the first report of using a RTX biosimilar to treat MCD. This case series demonstrates that RTX and ruxience are well-tolerated, efficacious treatment for managing adult patients with steroid-dependent MCD and relapses.

引用

页数：4

共 50 条

[21] Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy [J].

Benz, K ;

Dötsch, J ;

Rascher, W ;

Stachel, D .

PEDIATRIC NEPHROLOGY, 2004, 19 (07) :794-797

[22] Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome [J].

Miyabe, Yoei ;

Takei, Takashi ;

Iwabuchi, Yuko ;

Moriyama, Takahito ;

Nitta, Kosaku .

CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2016, 20 (01) :103-110

[23] Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome [J].

Yoei Miyabe ;

Takashi Takei ;

Yuko Iwabuchi ;

Takahito Moriyama ;

Kosaku Nitta .

Clinical and Experimental Nephrology, 2016, 20 :103-110

[24] Relapse during and after regular single-dose rituximab treatment in adult patients with steroid-dependent nephrotic syndrome [J].

Saito, Eiichiro ;

Oura, Atsushi ;

Kyo, Tetsuya ;

Ishigaki, Shun ;

Kamei, Hitomi ;

Nakamura, Yuki ;

Soma, Jun ;

Nakaya, Izaya .

CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, 28 (11) :1082-1089

[25] Obinutuzumab is effective for the treatment of frequently-relapsing/steroid-dependent minimal change disease in adults [J].

Jin, Li ;

Liu, Xueying ;

Li, Huixian ;

Dang, Xiangyun ;

Wang, Zhigang ;

Niu, Dan ;

Zhang, Xiaotian ;

Sun, Jiping ;

Hao, Dapeng ;

Lu, Wanhong .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (08) :1364-1367

[26] Extended infusion of rituximab combined with steroids is effective in inducing remission and reducing relapse in adult minimal change disease [J].

Diankun Liu ;

Zhanmei Zhou ;

Mengyi Wang ;

Sheng Nie ;

Jun Li ;

Bianxiang Hu ;

Wenjuan He ;

Guobao Wang ;

Jun Ai .

BMC Nephrology, 22

[27] Extended infusion of rituximab combined with steroids is effective in inducing remission and reducing relapse in adult minimal change disease [J].

Liu, Diankun ;

Zhou, Zhanmei ;

Wang, Mengyi ;

Nie, Sheng ;

Li, Jun ;

Hu, Bianxiang ;

He, Wenjuan ;

Wang, Guobao ;

Ai, Jun .

BMC NEPHROLOGY, 2021, 22 (01)

[28] Rituximab in Adult Minimal Change Disease and Focal Segmental Glomerulosclerosis [J].

Kronbichler, Andreas ;

Bruchfeld, Annette .

NEPHRON CLINICAL PRACTICE, 2014, 128 (3-4) :277-282

[29] Rituximab as Initial Therapy in Adult Patients With Minimal Change Disease [J].

Guan, Nan ;

Zhang, Min ;

Chen, Ruiying ;

Xie, Qionghong ;

Hao, Chuan-Ming .

KIDNEY INTERNATIONAL REPORTS, 2023, 8 (05) :1102-1104

[30] The efficacy of rituximab in adult frequently relapsing minimal change disease [J].

King, Catherine ;

Logan, Sarah ;

Smith, Stuart W. ;

Hewins, Peter .

CLINICAL KIDNEY JOURNAL, 2017, 10 (01) :16-19

← 1 2 3 4 5 →